SCHEMBL9520764

SCHEMBL9520764

COc1cccc2c1CCC2OC=O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.47
HSD11B1 P28845 1/20 0.47
HTR1A P08908 11/20 0.45
DRD2 P14416 7/20 0.45
DRD3 P35462 3/20 0.45
MEN1 O00255 2/20 0.45
CYP1A2 P05177 2/20 0.45
DRD4 P21917 2/20 0.45
HTR5A P47898 2/20 0.45
KMT2A Q03164 2/20 0.45
TSHR P16473 1/20 0.45
ADRA2A P08913 1/20 0.45
ADRA1A P35348 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CYP2D6 P10635 1/20 0.45
FFAR1 O14842 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9521719 0.91 CA1 (0.52) HSD11B1CA1CA2
SCHEMBL28019814 0.80 CYP19A1 (0.50) CYP19A1HSD11B1HTR1ADRD2DRD3
SCHEMBL9802470 0.74 SLC6A2 (0.42) HTR1AMEN1KMT2AADRA1ACA1
SCHEMBL28069851 0.74 CA1 (0.56) CYP19A1HSD11B1CA1CA2
SCHEMBL58026 0.74 IDO1 (0.59) CA1CA2FFAR1
SCHEMBL17014300 0.74 HTR1A (0.55) CYP19A1HSD11B1HTR1ADRD2DRD3
SCHEMBL14234001 0.74 IDO1 (0.59) CA1CA2FFAR1
SCHEMBL9017272 0.74 DRD2 (0.58) CYP19A1DRD2DRD3DRD4CA1
SCHEMBL15161143 0.73 CA1 (0.55) CYP19A1HSD11B1CA1CA2
SCHEMBL6804047 0.72 POLL (0.62) CYP19A1HSD11B1HTR1ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0325963-B1 1-AMINOMETHYL-1,2,3,4-TETRAHYDRONAPHTHALENES AND -INDANES ABBOTT LABORATORIES (US) 1993-09-22 EP disclosed
US-5140040-A Alpha-2-adrenergic receptor antagonist; glaucoma; congestive heart failure; hypotensive agents; headaches; metabolic disorders (diabetes, obesity) ABBOTT LABORATORIES (US) 1992-08-18 US disclosed
US-5128362-A Antidepressant, antiglaucoma ABBOTT LABORATORIES (US) 1992-07-07 US disclosed
US-5086074-A Selective adrenergic receptor antagonists ABBOTT LABORATORIES (US) 1992-02-04 US disclosed
EP-0395734-A4 1-AMINOMETHYL-1,2,3,4-TETRAHYDRONAPHTHALENES 1991-01-02 EP disclosed
EP-0395734-A1 1-AMINOMETHYL-1,2,3,4-TETRAHYDRONAPHTHALENES ABBOTT LABORATORIES (US) 1990-11-07 EP disclosed
EP-0325963-A1 1-Aminomethyl-1,2,3,4-tetrahydronaphthalenes and -indanes ABBOTT LABORATORIES (US) 1989-08-02 EP disclosed
WO-1989006645-A1 1-AMINOMETHYL-1,2,3,4-TETRAHYDRONAPHTHALENES ABBOTT LABORATORIES (US) 1989-07-27 WO disclosed